Wellgistics Health, Inc. (WGRX) Stock Price & Analysis
Wellgistics Health, Inc. (WGRX) rose 0.00% to USD 3.52 as of July 25, 2026 at 09:52 UTC, according to Nexqual real-time market data.
WGRX last closed at USD 0; the session ranged USD 2.72–3.79 on volume of 536,280 shares. Market capitalization is $182.88M, with a 52-week range of USD 2.49–97.5 (NCM). Source: Nexqual, July 25, 2026 at 09:52 UTC.
Key Statistics (as of July 25, 2026 at 09:52 UTC)
| Price | USD 3.52 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 2.72 |
| Day Range | USD 2.72 – 3.79 |
| 52-Week Range | USD 2.49 – 97.5 |
| Volume | 536,280 shares |
| Market Cap | $182.88M |
| Exchange | NCM |
Technical Analysis (WGRX)
Nexqual's technical model rates WGRX "NEUTRAL" based on 2 bullish and 3 bearish signals across 123 daily candles, as of July 25, 2026 at 09:52 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.84 (neutral) |
| vs SMA50 | Below (USD 3.79) |
| MACD | -0.18 (negative) |
Analyst Ratings (WGRX)
Wall Street analysts rate WGRX "None", per Nexqual as of July 25, 2026 at 09:52 UTC.
| Consensus Rating | None |
|---|
Earnings (WGRX)
Source: Nexqual, July 25, 2026 at 09:52 UTC.
Financials & Fundamentals (WGRX)
| Total Revenue | $14.03M |
|---|---|
| Revenue Growth (YoY) | -85.60% |
| Gross Margin | -49.51% |
| Operating Margin | -385.72% |
| Profit Margin | +0.00% |
| Current Ratio | 0.09 |
| Total Cash | $51,730 |
| Total Debt | $28.73M |
| Free Cash Flow | $-6.76M |
Source: Nexqual, July 25, 2026 at 09:52 UTC.
Financial Health Score (WGRX)
Nexqual rates Wellgistics Health, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 09:52 UTC.
| Growth | Critical — Revenue -86% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $52K cash vs $29M debt |
| Cash Flow | Weak — FCF negative: -$7M, burning cash |
| Efficiency | Mixed — No data |
Ownership (WGRX)
| Insider Ownership | +68.38% |
|---|---|
| Institutional Ownership | +1.70% |
| Shares Outstanding | 51.96M |
| Float | 614,458 |
| Short % of Float | +7.18% |
Source: Nexqual, July 25, 2026 at 09:52 UTC.
Leadership (WGRX)
Wellgistics Health, Inc. is led by Prashant Patel M.Sc., R.Ph. (age 50), Interim Co-CEO, President & Director, per Nexqual as of July 25, 2026 at 09:52 UTC.
| Interim Co-CEO, President & Director | Prashant Patel M.Sc., R.Ph. (age 50) |
|---|---|
| Senior Vice President of Pharmacy | Nikul Panchal BCNP, R.Ph. (age 47) |
Major Backers & Investors (WGRX)
Notable institutional backers of Wellgistics Health, Inc. include Fidelity, according to Nexqual as of July 25, 2026 at 09:52 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.49% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.21% |
| Geode Capital | 0.57% |
Source: Nexqual, July 25, 2026 at 09:52 UTC.
From Wellgistics Health, Inc.'s Latest SEC 10-K Filing (filed 2026-03-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.
- The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products.
- It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
- It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SCNX | Scienture Holdings, Inc. | USD 0.37 | ▼ 7.75% |
| YYAI | AiRWA Inc. | USD 11.33 | ▲ 38.18% |
| XHLD | TEN Holdings, Inc. | USD 1.86 | ▼ 11% |
| VSEE | VSee Health, Inc. | USD 0.08 | ▼ 1.25% |
| PFSA | Profusa, Inc. | USD 1.71 | ▼ 10% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:52 UTC. This page is informational and not investment advice.